As shown in Figure 6A, high SLC2A1 expression was associated with poor OS in patients with ACC (p = 0.0042), KIRP (p = 0.026), brain lower grade glioma (LGG) (p = 0.017), LIHC (p < 0.001), LUAD (p < 0.001), PAAD (p = 0.0049), SARC (p = 0.013), and SKCM (p = 0.0028). The gene discussed is SLC2A1; the disease is adrenal cortex carcinoma.